AllDocs -> cancers

M EET DR . C H U Prevent Colon Cancer : Get Screened SiteNews and Notes = Kings County Hospital Center (KCHC) has a new dialysis unit. Eachofthe 24stationsin the outpatientunit has a state-of- the-art machine,its own ward- robe, and cable TV. The unit han- dlesthree shifts ofpatientsdaily. KCHC is at451 ClarksonAve., Brooklyn. = Ambulatory Surgeryservices at Bellevue Hospital Center are easiertouse.You wait much lesstimefor an appointment. Bellevueis at462 First Ave., Manhattan. Every year, more than 1,500 New Yorkers die of colon cancer . Many of these deaths could be prevented. When colon cancer is found early, it is much easier to cure. Screening is the key. Who Needs Screening? Anyone at normal risk for colon cancer should be screened starting at age 50. If you have a family ...

Colon Cancer Screening Diet and screening can protect greatly from this cancer . W hile many have become increasingly concerned about the possible connections between diet and cancer , this is particularly true of cancer of the colon . Population studies of oriental (Japanese and Chinese) immigrants to America show an increase in colon cancer once they have adapted a more westernized diet. In the 1995 edition of Conn’s Current Therapy, Drs. Steven Wexner and Juan Nogueras state, "numerous stud- ies confirm that increased consumption of dietary fat, especially animal fat, is associated with the development of colorectal cancer . Other factors, such as obesity and a sedentary lifestyle, are also associated with colorectal cancer . Recently, cigarette smoking has been implicated in the development of colorectal adenomatous polyps." Additional ...

Colon Cancer :It’sTime to Talk Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that connects the small intestine to the rectum. Cancer can begin in any part of the colon , but before cancer develops, changes usually occur in the organ’s lining. One change is a tissue growth called a polyp, which is a benign growth that can become malignant (cancerous) over time. Once detected, a polyp may be removed, preventing it from becoming cancerous. Who is at risk? • People over 50 • People with a personal history of colon or rectal cancer or chronic inflammatory bowel disease • People with a strong family history of colon or rectal cancer or polyps, or any type of cancer • People who are physically inactive • People who eat high-fat, low-fiber diets • Tobacco users What are the symptoms? • A change in bowel habits lasting for more ...

Eastern Carolina Family Practice Center 7/04 RL 6.0 Nutrition Prevention for Colon Cancer What is colon cancer ? Colon cancer is an abnormal growth of cells in the large intestine or the colon . When cells in the colon fail to grow, divide and reproduce in a healthy way, abnormal tissue is provided and a growth called a polyp is formed. These polyps can grow and become malignant (cancerous) growths that can spread to other parts of the body. What you can do to prevent colon cancer 1. Stay lean. Achieve and maintain a health weight. • Be physically active. Activity stimulates movement through the bowel, reducing the length of time that bowel lining is exposed to mutagens. • Avoid obesity or gaining weight. Obesity increases the risk of colon cancer . 2. Eat more fruits, vegetables, and grains. • Choose most of the foods you eat from plant sources. ...

1.800.ACS.2345 www. cancer .org Hope.Progress.Answers. ® ©2005, American Cancer Society, Inc. No. 2432.00 The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer , saving lives, and diminishing suffering from cancer , through research, education, advocacy, and service. No matter who you are, we can help. Contact us anytime, day or night, for information and support. Talk to your doctor about getting tested for colon cancer . Here are some questions to help you get started. If you’re 50 or older, you need to get tested for colon cancer . No matter how good your excuse is. “I’m scared they’ll ...

To Prevent and Cure Cancer T he Arizona Cancer Center’s Colon Cancer Program is dedicated to creating a clinical and basic research program that prevents colon cancer and cures patients with the disease. Colon cancer is a preventable and curable disease if diagnosed at an early stage. This year in the state of Arizona, colon cancer will be diagnosed in 2,000 people, and 900 will die from it. The Colon Cancer Program team, under the direction of David S. Alberts, M.D., is committed to stamping out this disease. One way this goal is being accomplished is through the team’s drug development efforts, which include developing specific targets for drug action, synthesizing novel molecules, screening for anticancer and preventive activities, completing toxicologic testing, and designing and performing early stage clinical trials ...

[Frontiers in Bioscience 2, d460-470, September 15, 1997] 460 ACTION OF POLYPEPTIDE GROWTH FACTORS IN COLON CANCER ; DEVELOPMENT OF NEW THERAPEUTIC APPROACHES Subhas Chakrabarty, Sharon Reynolds, Hong mei Wang and Sriram Rajagopal Division of Laboratory Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Discussion 3.1. Adhesion molecules and TGF-beta 3.2. Mechanisms of action of TGF-beta in colon cancer , role of protein kinase C 3.3. PKC alpha-a potential therapeutic target 3.4. EGF family of growth factors and the potential of EGF receptor as a therapeutic target 3.5. Other potential therapeutic targets 3.6. Therapeutic approach 3.7. Basis of selectivity against colon cancer 3.8. Perspectives 4. Acknowledgments 5. References 1. ABSTRACT ...

MOLECULAR PATHOLOGY OF HEREDITARY COLON CANCER Reijo Salovaara Department of Pathology and Department of Medical Genetics Haartman Institute and Biomedicum University of Helsinki Finland Academic Dissertation To be publicly discussed with the permission of Medical Faculty of the University of Helsinki, in the large lecture hall of the Haartman Institute, Haartmaninkatu 3, Helsinki, November 26 th , 2004 at 12 noon. Helsinki 2004 Page 2 Supervised by Lauri A Aaltonen, MD, PhD Professor Research Professor of the Finnish Academy of Sciencies Department of Medical Genetics Biomedicum University of Helsinki Finland Albert de la Chapelle, MD, PhD Professor Director, Human Cancer Genetics Program Comprehensive Cancer Center The Ohio State University United ...

Relative Incidence of Cancer within the Colon in a Population with a Historically High Incidence Rate Eugene J. Lengerich, VMD Juan Wu, MS Alan MacEachren, PhD James Hobley, MD Roxanne Parrott, PhD Thomas McGarrity, MD Brenda Kluhsman, MSS Previous studies have reported substantial variation in the magnitude of the effect of behavioral and genetic risk factors and the efficacy of selected treatment for cancer of specific anatomical sites within the colon . In addition, the utilization of colon cancer imaging has varied by demographic group and geographic location. The purpose of this study was to estimate the incidence of colon cancer and to determine if relative rates were similar for demographic groups and residences in a large geographic area with a historically elevated incidence. This population-based study took place in Pennsylvania which had the 3 rd ...

Practice Parameters Practice Parameters for Colon Cancer Prepared by The Standards Practice Task Force The American Society of Colon and Rectal Surgeons Daniel Otchy, M.D., Neil H. Hyman, M.D., Clifford Simmang, M.D., Thomas Anthony, M.D., W. Donald Buie, M.D., Peter Cataldo, M.D., James Church, M.D., Jeffrey Cohen, M.D., Frederick Dentsman, M.D., C. Neal Ellis, M.D., John W. Kilkenny III, M.D., Clifford Ko, M.D., Richard Moore, M.D., Charles Orsay, M.D., Ronald Place, M.D., Janice Rafferty, M.D., Jan Rakinic, M.D., Paul Savoca, M.D., Joe Tjandra, M.D., Mark Whiteford, M.D. The American Society of Colon and Rectal Surgeons is dedicated to assuring high quality patient care by advancing the science, prevention, and management of disorders and diseases of the colon , rectum, and anus. The Standards Committee is composed of Society members who are chosen because they have ...

ACGME Competencies Project PAIN MANAGEMENT Pre-Test Pain Management Pre-Test (9-17-04) Page 1 Number Question 1. A patient with metastatic colon cancer requires his dose of MS0 4 to be increased because of increasingly severe pain, rated as 7 out of 10. The most common explanation for the need to raise the MS0 4 dose in this patient is: A. Change in the distribution of the drug B. Decreased absorption of the drug C. Decreased receptor sensitivity to the drug D. Increased clearance of the drug E. Worsening of the underlying disease 2. For patients receiving opioids for analgesia, physical dependence exists when: A. Medications are used for purposes other than analgesia B. Patients continue to use despite harm C. Patients develop a withdrawal syndrome upon discontinuance D. There is loss ...

inhibits the cancer -promoting role of high dietary fat by binding soluble fatty acids and bile acids in the colonic lumen to form insoluble calcium complexes. Calcium may also protect against colon cancer by directly inhibiting proliferation and inducing more normal differentiation or apoptosis (cell death) of colonic epithelial cells. A recent double-blind, placebo-controlled clinical trial in over 900 patients at high risk for colon cancer found that increasing calcium intake by1200mg/day significantly reduced the recurrence of adenomas. Although the trial lasted four years, a reduction in risk was evident in less than one year. Dairy foods are an important source of CLA, sphingolipids, and butyric acid, each of which has been demonstrated to inhibit colon cancer or early forms of this disease in experimental animal and in vitro studies. Likewise, probiotic ...

for colorectal cancer screening by the recognized scientific bodies, and is not paid for by Medicare or private insurers. Any patients who anticipate trying this technique would probably want to assure that the newer 3-D imaging using multi-slice scanning is used, rather than the more readily available but less reliable 2-D equipment. • The risks related to radiation with CT colonography remain uncertain. Fecal DNA Testing: This test involves collection of a stool sample at home that is mailed to a central laboratory. The laboratory checks for abnormal DNA shed from the surface of colon cancers and polyps. • The test detects 52% of colon cancers and 15% of large polyps. If negative it is repeated every 3 to 5 years. This test is better than a stool blood test but much more expensive. Fecal DNA testing is not nearly as effective as ...

Technology Evaluation Center BlueCross BlueShield Association ® ® An Association of Independent Blue Cross and Blue Shield Plans ©2004 Blue Cross and Blue Shield Association. Reproduction without prior authorization is prohibited. 1 NOTICE OF PURPOSE: TEC Assessments are scientific opinions, provided solely for informational purposes. TEC Assessments should not be construed to suggest that the Blue Cross Blue Shield Association, Kaiser Permanente Medical Care Program or the TEC Program recommends, advocates, requires, encourages, or discourages any particular treatment, procedure, or service; any particular course of treatment, procedure, or service; or the payment or non-payment of the technology or technologies evaluated. Assessment Program Volume 19, No. 6 July 2004 Executive Summary Computed tomographic (CT) colonography, ...

Title: Optical Image Analysis For The Diagnosis Of Colon Cancer Abstract: Introduction . Colon cancer and its pre-cursors alter the macro- architecture of the colon tissue. Common changes include angiogenesis and distortion of mucosal and submucosal collagen matrix. Such changes affect the colon colouration, but may not be discerned by the human eye. This paper presents principles of a novel optical imaging method which produces histologically informative images showing spatial distribution and quantities associated with blood and collagen. Methods . A computational, physics-based model of light interaction with tissue predicts colours associated with a specific instance of the colon tissue. The colon structure is represented by four layers: mucosa, submucosa, muscularis externa propria and serosa. Optical properties of the layers are defined by molar concentration and absorption ...

STOP COLON /RECTAL CANCER FOUNDATION RISK ASSESSMENT QUESTIONNAIRE Please answer the following questions. 1. Are you age 50 or older? Yes No 2. Have you ever had polyps or cancer of the colon or rectum? Yes No 3. Do you have any CLOSE family members (parents, grandparents, siblings) who have had polyps or cancer of the colon or rectum? Yes No 4. Have you ever been told that you have ulcerative colitis or Crohn’s disease? Yes No 5. If you are female, have you ever had breast, uterine or ovarian cancer ? Yes No AVERAGE RISK: Yes to question 1, No to the remaining questions. INCREASED RISK: Yes or No to question 1, Yes to any of the remaining questions. • Discuss your test options with your doctor today. • If you have noticed any change in your bowel movements, seen blood or experienced abdominal discomfort, you should see your doctor right away. It’s a ...

April 22, 2003 A.S. Perkins Page 1 Biology 315b Lecture #5 Inherited Cancer Syndromes and Colon Cancer Required reading: Kumar, Cotran, Robbins, Basic Pathology, Chapter 15, pp. 504-515. Redston, M. 2001. Carcinogenesis in the GI tract: From morphology to genetics and back again. Mod Pathol 14: 236-245. Repair of DNA Damage In previous sections, it is clear that the integrity of the cell’s DNA is under mutagenic attack from chemical carcinogens, ionizing radiation, and ultraviolet light (e.g., thymidine dimers, Figure 2 ). In addition, spontaneous deamination, depurination, and tautomerization threaten the integrity of DNA (Figure 3 ). These can occur due to spontaneous oxidation, hydrolysis, or inappropriate methylation of the bases in DNA ( Figure 4) . There are four major systems that correct DNA damage, and each is tailored to a particular type of damage. In normal individuals, ...

INTRODUCTION Colorectal cancer is still a leading cause of cancer deaths in the United States and is increasing at an alarming rate in Asia (1, 2). Cancer chemoprevention is a discipline of cancer research emerging from its infancy 20 yr ago to now gain center stage in the armamentarium against cancer (3). Yet it has not abandoned its founding principles of discovery of natural and man-made agents that inhibit the initiation, promotion, or progression of cancer . The pioneering efforts of Wattenberg (4, 5) first focused the search for chemopre- ventive agents by examining the diet for them. Dietary pat- terns may account for wide differences in the risk for lead- ing cancers across the world. It was logical to propose that dietary factors, in countries with populations at low risk for certain cancers could be identified and exploited for use in man as cancer inhibitors (6). From the ...

Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance W.M. Schmidt 1 , M. Kalipciyan 2 , E. Dornstauder 1 , B. Rizovski 2 , R. Sedivy 3 , G.G. Steger 2 , M.W. Müller 1 and R.M. Mader 2 1 VBC-Genomics Bioscience Research Inc., 2 Department of Medicine I, Clinical Division of Oncology, and 3 Department of Clinical Pathology, University Hospital, Vienna Austria Molecular resistance to 5-fluorouracil Introduction Resistance to anticancer drugs is a major obstacletochemotherapyof humancancer.In patients with metastasized colorectal carci- noma, resistance to the widely used antimeta- bolite 5-fluorouracil seriously limits therapeu- tic ...

Abstract . Caveolin-1, -2, and -3 are the principal proteins of caveolae, the vesicular invaginations of the plasma membrane. Recent studies suggest that caveolins play an important role in cellular signaling and, possibly, in tumorigenesis. We examined the expression of the three caveolins in azoxy- methane-induced rat colon adenocarcinoma and normal- appearing colonic mucosa, and also in human colon cancer cells with inherently different proliferation rates. Expression of caveolins was assessed in experimental rat colon adeno- carcinoma and normal-appearing colonic tissues by RT-PCR, immunoblot and immunohistochemistry. Expression of caveolin-1, -2, and -3 at protein and mRNA levels in human colon cancer cell lines Caco-2, HT-29 and HCT-116 was assessed by immunoblot and RT-PCR, respectively. While caveolin-1 was overexpressed in all experimental adeno- carcinoma tissues by comparison ...

Contact: William A. Hockett Vice President of Corporate Communications (801) 584-3600 Email: bhockett@myriad.com www.myriad.com FOR IMMEDIATE RELEASE New Colon Cancer Gene Licensed Exclusively to Myriad Genetics Myriad’s Predictive Medicine Sample Flow Continues to Grow Salt Lake City, April 14, 2004 -Myriad Genetics, Inc. (Nasdaq: MYGN), announced today that it has licensed exclusive rights in the United States to detect mutations in an important new colon cancer gene. Myriad believes that the new colon cancer gene, known as Mut Y Homolog (MYH), will provide improved sensitivity and predictive utility to the Company’s COLARIS® product line for detecting all major forms of hereditary colon cancer . The Company expects to introduce the enhanced test during the next quarter as an integral component of its COLARIS range of products, and also as ...

MJA Vol 180 5 April 2004 341 MEDICINE AND THE LAW The Medical Journal of Australia ISSN: 0025-729X 5 April 2004 180 7 341-342 ©The Medical Journal of Australia 2004 www.mja.com.au Medicine and the Law T HERE ARE IMPORTANT DISTINCTIONS to be made between the inquisitorial process of a tribunal, such as the South Australian Workers Compensation Tribunal, and the adversarial process of the courts. To quote the renowned English Law Lord, Lord Devlin: In the [adversarial process], the judge presides at the trial, directs the proceedings and rules on the law; he is not there to hold an inquiry. It is quite different from the [inquisitorial process] where witnesses are summoned by the court and examined by the judges, the role of counsel being to tender a witness, and ask supplementary questions. 1 A tribunal is inquisitorial. It ...

Unexplained Inversion of the Incidence Ratio of Colon and Rectal Cancer among Men in East Germany Stang A 1 , Stabenow R 2 , Stegmaier C 3 , Eisinger B 2 , Bischoff-Hammes E 1,4 , Jöckel KH 4 1 Institute of Medical Epidemiology, Biometry and Informatics, Medical Faculty, Martin-Luther-University of Halle-Wittenberg, Magdeburger Str. 27, 06097 Halle, Germany 2 Common Cancer Registry of Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt, and the Free States of Sachsen and Thüringen (GKR), Brodauer Str. 16-22, 12621 Berlin, Germany 3 Saarland Cancer Registry, Virchowstr. 7, 66119 Saarbrücken, Germany 4 Institute of Medical Informatics, Biometry and Epidemiology, University Hospital, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany ...

FDA approves Xeloda for adjuvant Dukes' C colon cancer From: Richard Pazdur, MD Director, Division of Oncology Drug Products, Center for Drug Evaluation and Research, FDA On June 15, 2005, the U.S. Food and Drug Administration approved capecitabine (Xeloda (r) Tablets, Hoffman-LaRoche Inc.) as a single-agent adjuvant treatment for Dukes' stage C colon cancer patients who have undergone complete resection of the primary tumor in those instances when fluoropyrimidine therapy alone would be preferred. Approval is based on non-inferiority in disease-free survival (DFS) to bolus 5-fluorouracil plus leucovorin (5-FU/LV). In 2004, the FDA approved oxaliplatin for injection (Eloxatin(tm)) in combination with infusional 5-FU/LV for adjuvant stage III colon cancer . Although neither capecitabine nor the combination of oxaliplatin plus 5-FU/LV prolonged overall survival in the adjuvant setting, ...

Korean J Radiol 2(4), December 2001 235 Phlegmonous Enteritis in a Patient with Congestive Heart Failure and Colon Cancer Phlegmonous enteritis is a rare infective inflammatory disease of the intestine, predominantly involving the submucosal layer. It is difficult to diagnose and often fatal. Its association with alcoholism and various liver diseases, although rarely reported, is well documented. We report a case of phlegmonous enteritis in a male patient with congestive heart failure and colon cancer , and describe the ultrasonographic and CT findings. hlegmonous gastritis and phlegmonous enterocolitis are rare types of gas- trointestinal tract infection, and have been observed in association with alcoholism and hepatic cirrhosis (1 5). They may, however, also be found in healthy subjects (6). Although mucosal lesions can be present and inflamma- tion may extend to the ...

RADIATION ENHANCES AZOXYMETHANE-INDUCED COLON CANCER DEVELOPMENT N.D. Turner 1 , N. Popovic 1 , M.Y. Hong 1 , S.S. Taddeo 1 , L.A. Davidson 1 , L.A. Braby 2 , J.R. Ford 2 , Q. Zheng 3 , D.V. Nguyen 4 , R.J. Carroll 3 , R.S. Chapkin 1 , and J.R. Lupton 1 1 Texas A&M University, Faculty of Nutrition, 2471 TAMU, 2 Texas A&M University, Department of Nuclear Science, 3133 TAMU 3 Texas A&M University, Department of Statistics, 3143 TAMU, College Station, TX, 4 University of California, School of Medicine, Davis, CA. INTRODUCTION The combined effects of radiation and chemical carcinogen exposure on colon cancer development have not been extensively studied. ...

COLON CANCER PREVENTIVE SCREENING Cancer of the lower intestine ( colon ) is the second leading cause of cancer death in the United States. Only lung cancer exceeds colon cancer in deaths per year. Colon cancers develop from small outgrowths of the lining layer called polyps. At first polyps are benign but can change over many years into malignant tumors that enlarge and can metastasize to the liver and elsewhere. Early detection and removal of the polyps prevent the development of malignant tumors, with its associated pain, disability and possible death. In addition, detection and removal of polyps saves major healthcare expense resulting from the hospitalization, surgery and follow-up care of a future malignant colon tumor. Techniques to detect colon polyps continue to evolve. COLONOSCOPY • Use of a fiber optic flexible instrument inserted through the colon (colonoscope) is the ...

Figure 1: Colon cancer data set (Alon et al., 1999): boxplots representing the training set accuracy, the LOO-CV and the test set accuracy of all numerical experiments. Legend: 1 = training set accuracy of LS-SVM with a linear kernel, 2 = LOO-CV performance of LS-SVM with a linear kernel, 3 = test set accuracy of LS-SVM with a linear kernel, 4 = training set accuracy of LS-SVM with an RBF kernel, 5 = LOO-CV performance of LS-SVM with an RBF kernel, 6 = test set accuracy of LS-SVM with an RBF kernel, 7 = training set accuracy of LS-SVM with a linear kernel without regularization, 8 = LOO-CV performance of LS-SVM with a linear kernel without regularization, 9 = test set accuracy of LS-SVM with a linear kernel without regularization, 10 = training set accuracy of PCA + FDA (selection of PC based on eigenval- ues), 11 = LOO-CV performance of PCA + FDA (selection of PC based on eigenvalues), 12 = test set accuracy of PCA + FDA ...

Colon cancer data set (Alon et al., 1999): statistical significance tests on test set accuracy experiments 1 2 3 4 5 6 7 8 9 1 1.000000 0.492188 0.000059 0.203613 0.010278 0.203613 0.010278 0.006836 0.000082 2 0.492188 1.000000 0.000059 0.497314 0.015219 0.497314 0.015219 0.041992 0.000127 3 0.000059 0.000059 1.000000 0.000059 0.000059 0.000059 0.000059 0.000074 0.001071 4 0.203613 0.497314 0.000059 1.000000 0.050996 1.000000 0.050996 0.064453 0.000149 5 0.010278 0.015219 0.000059 0.050996 1.000000 0.050996 1.000000 0.895670 0.000185 6 0.203613 0.497314 0.000059 1.000000 0.050996 1.000000 0.050996 0.064453 0.000149 ...